Segmentation by types of Clinical Contract Research Services distinguishes the business models through which CROs capture value. The full‑service CRO model delivers end‑to‑end solutions—from study design and site management to data analytics and regulatory submission—capturing the majority of high‑complexity contracts and contributing the largest proportion of market revenue. Functional service providers (FSPs) specialize in discrete activities such as biostatistics, medical writing, or pharmacovigilance; their focused expertise enables cost‑efficient outsourcing and collectively represent a significant, though smaller, slice of the market. Niche specialists concentrate on therapeutic areas (e.g., oncology, rare diseases) or emerging modalities (e.g., gene therapy), commanding premium fees for deep scientific knowledge and tailored operational frameworks. Hybrid models combine elements of full‑service and functional offerings, allowing clients to modularly assemble service bundles. Each type adds distinct revenue streams, with full‑service CROs driving the core market size, functional providers expanding the breadth of outsourcing, and niche specialists enhancing depth, together shaping the comprehensive market taxonomy for Clinical Contract Research Services.